Additionally, among the several tumor-associated glycosyltransferases, MGAT3 mRNA expression were found to be negatively correlated with imputed drug resistance scores in BC patients (Fig. 1I, S1F-I). This evidence concerns the gene MGAT3 and breast cancer.